15-min delayed · Jul 27, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 4 firms covering NioCorp Developments Ltd. Common Stock, 4 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets are tightly clustered, $8.70 to $12.00, so the covering firms are broadly aligned. The average target of $10.23 sits 144% above the current $4.20. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.04 next quarter toward $-0.24 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS4 ratings
Moderate Buy
Strong Buy00%
Buy4100%
Hold00%
Sell00%
Strong Sell00%
Based on 4 analysts giving stock ratings to NioCorp Developments Ltd. Common Stock.
As of Jul, 4 of 4 firms rate NB a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
NB EPS & revenue forecast
EPS · NEXT QUARTER
$-0.04
Range $-0.04 – $-0.04 · 2 analysts · -92% YoY
Next period, 2 analysts expect NioCorp Developments Ltd. Common Stock to earn $-0.04 a share (range $-0.04 – $-0.04), versus $-0.53 a year earlier. , growing to $-0.24 the year after.
REVENUE · NEXT QUARTER
$0
Range $0 – $0 · 2 analysts
Revenue is expected to reach $0 (range $0 – $0)., rising to $0 next year.
Top analysts covering NioCorp Developments Ltd. Common Stock
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on NB.
#1
Heiko F. Ihle
HC Wainwright & Co. · Rank #30
Buy
$10.00+138.1% to target
Overall win rate
42%
+ Follow
#2
Tate Sullivan
Maxim Group · Rank #315
Buy
$5.00+19.0% to target
Overall win rate
34%
+ Follow
#3
VK
Vitaly Kononov
Freedom Broker
Buy
$8.70+107.1% to target
Coverage
—
+ Follow
#4
Neal Dingmann
William Blair
Buy
No targeton NB
Coverage
—
+ Follow
NB stock forecast FAQ
What is NB's average 12-month price target?+
The 2 analysts with a live target average $10.23 for NioCorp Developments Ltd. Common Stock over the next 12 months, ranging from a $12.00 high to a $8.70 low.
Is NB stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 4 analyst ratings, 4 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for NB?+
The Street-high target is $12.00, and the Street-low is $8.70 (Freedom Broker). The average of all 2 active targets is $10.23.
How many Wall Street analysts cover NB?+
4 analysts have an active rating on NioCorp Developments Ltd. Common Stock, and 2 firms carry a live 12-month price target.
Who is the most accurate analyst covering NB?+
Among analysts who currently cover NB, Heiko F. Ihle of HC Wainwright & Co. has the strongest overall Quantellect track record (Rank #30). Their current call is Buy with a $10.00 target.
What is NioCorp Developments Ltd. Common Stock's projected EPS for next quarter?+
The consensus estimate is $-0.04 per share (range $-0.04 – $-0.04) across 2 analysts, rising to $-0.24 the following year.
How much revenue is NioCorp Developments Ltd. Common Stock expected to report next quarter?+
Consensus revenue is $0 (range $0 – $0), growing to $0 next year.
Have analysts been upgrading or downgrading NB lately?+
As of Jul, 4 of 4 firms rate NB a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their NB calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
